Home › Funds › FAYEZ SAROFIM & CO › AZN

FAYEZ SAROFIM & CO position in AZN

ASTRAZENECA PLC · Health Care

FAYEZ SAROFIM & CO reported holding 2,197,838 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$354.6M, representing 0.85% of its reported portfolio and ranking #28 among its reported holdings. FAYEZ SAROFIM & CO has disclosed AZN holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.20M sh
Reported value held$354.59M
Portfolio Weight0.85%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How FAYEZ SAROFIM & CO's AZN position evolved

FAYEZ SAROFIM & CO first disclosed a stake in AZN in Q3 2023 at 2,108,216 shares (US$142.8M). The position peaked in Q4 2025 at 4,258,640 shares, worth US$391.5M. Across 12 filings, FAYEZ SAROFIM & CO increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,197,838 shares valued at US$354.6M — an increase of 2,018,245 shares quarter over quarter.. Notable position changes include a 62% trim in Q1 2025 (shares fell 5% over the following quarter), a 173% increase in Q2 2025 (shares rose 11% over the following quarter), a 1124% increase in Q3 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.11M $142.77M New
Q4 2023 2.86M $177.78M Add
Q1 2024 2.99M $202.59M Add
Q2 2024 3.24M $252.62M Add
Q3 2024 3.44M $268.32M Add
Q4 2024 3.64M $238.69M Add
Q1 2025 1.37M $272.16M Reduce
Q2 2025 3.75M $261.76M Add
Q3 2025 3.89M $298.78M Add
Q4 2025 4.26M $391.50M Add
Q2 2026 179.59K $34.05M New
Q3 2026 2.20M $354.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 65 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has FAYEZ SAROFIM & CO held AZN?

FAYEZ SAROFIM & CO has disclosed AZN holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is FAYEZ SAROFIM & CO's current position in AZN?

As of Q3 2026, FAYEZ SAROFIM & CO holds 2.20M shares of AZN (ASTRAZENECA PLC), valued at $354.59M, representing 0.85% of its reported portfolio and ranking #28.

Has FAYEZ SAROFIM & CO been buying or selling AZN?

In the latest 13F filing (Q3 2026), FAYEZ SAROFIM & CO increased its position in AZN. The position peaked in Q4 2025 at 4.26M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.